Hypotension Prediction Index in Patients Undergoing Liver Transplantation

May 3, 2021 updated by: Chang Gung Memorial Hospital

Performance of the Hypotension Prediction Index With Invasive Arterial Pressure Waveform in Liver Transplantation

A prospective, open-label and single-center study to determine whether the use of Acumen Hypotension Prediction Index software predicts the occurrence of hypotension.

Study Overview

Status

Recruiting

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Taoyuan City, Taiwan, 333
        • Recruiting
        • Chang Gung Memorial Hospital
        • Contact:
          • Yung Fong Tsai, PHD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Written informed consent
  • Age ≥ 20 years;
  • Scheduled liver transplantation
  • Planned pressure monitoring with an arterial line;
  • General anesthesia

Exclusion Criteria:

  • Contraindication for invasive blood pressure monitoring
  • End-staged renal disease
  • pre-operative MAP <65 mmHg
  • Severe heart failure
  • Severe cardiac shunt
  • Severe aortic stenosis
  • Severe atrial fibrillation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Acumen HPI-enabled EV1000 screen
Acumen HPI-enabled EV1000 screen record the incidence of intraoperative hypotension

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Accurate hypotension prediction of EV1000 system
Time Frame: MAP measurements of each case were recorded every 20 s by the EV1000 system from induction to the end of surgery, assessed up to 1 day.
Analyze the actual incidence of hypotension after HPI alarm more than 85 within 15 min
MAP measurements of each case were recorded every 20 s by the EV1000 system from induction to the end of surgery, assessed up to 1 day.
Incidence of intraoperative hypotension
Time Frame: MAP measurements of each case were recorded every 20 s by the EV1000 system from induction to the end of surgery, assessed up to 1 day
Frequency, duration of intraoperative hypotension, which defined as MAP < 65 mmHg at least 1 min
MAP measurements of each case were recorded every 20 s by the EV1000 system from induction to the end of surgery, assessed up to 1 day
Severity of intraoperative hypotension
Time Frame: MAP measurements of each case were recorded every 20 s by the EV1000 system from induction to the end of surgery, assessed up to 1 day
MAP measurements were recorded every 20 s by the EV1000 system from induction to Time-weighted average mean arterial pressure (TWA-MAP) < 65 mmHg
MAP measurements of each case were recorded every 20 s by the EV1000 system from induction to the end of surgery, assessed up to 1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hospital stay and ICU stay
Time Frame: Days from admission to discharge, assessed up to 1 month
The incidence and severity of intraoperative hypotension correlate with patient's hospital stay and ICU stay
Days from admission to discharge, assessed up to 1 month
Mortality after surgery
Time Frame: Days from admission to discharge, assessed up to 1 month
The incidence and severity of intraoperative hypotension correlate with patient's mortality
Days from admission to discharge, assessed up to 1 month
Adverse effects
Time Frame: Days from admission to discharge, assessed up to 1 month
The incidence and severity of hypotension correlate with the adverse effects like acute liver failure, acute kidney injury and acute myocardial injury
Days from admission to discharge, assessed up to 1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

May 1, 2021

Primary Completion (Anticipated)

February 1, 2024

Study Completion (Anticipated)

February 1, 2024

Study Registration Dates

First Submitted

April 26, 2021

First Submitted That Met QC Criteria

May 3, 2021

First Posted (Actual)

May 4, 2021

Study Record Updates

Last Update Posted (Actual)

May 4, 2021

Last Update Submitted That Met QC Criteria

May 3, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Hypotension prediction index

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intraoperative Hypotension

Clinical Trials on Acumen HPI-enabled EV1000 screen

Subscribe